作者: Karin Louise Richter
DOI:
关键词:
摘要: There is now enough scientific evidence available to predict that conventional cervical cancer screening with cytology will eventually be replaced by testing for markers of HPV infection associated disease progression. It vital clinicians understand the benefits, limitations and harms testing. False-positives can reduced adhering guidelines age-related recommended longer intervals. Patients must well informed regarding role in screening.